Reduced Expression of HLA Class II Molecules and Interleukin-10- and Transforming Growth Factor β1-Independent Suppression of T-Cell Proliferation in Human Cytomegalovirus-Infected Macrophage Cultures
Open Access
- 1 June 2001
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 75 (11) , 5174-5181
- https://doi.org/10.1128/jvi.75.11.5174-5181.2001
Abstract
After a primary infection, human cytomegalovirus (HCMV) establishes lifelong latency in myeloid lineage cells, and the virus has developed several mechanisms to avoid immune recognition and destruction of infected cells. In this study, we show that HCMV utilizes two different strategies to reduce the constitutive expression of HLA-DR, -DP, and -DQ on infected macrophages and that infected macrophages are unable to stimulate a specific CD4+ T-cell response. Downregulation of the HLA class II molecules was observed in 90% of the donor samples and occurred in two phases: at an early (1 day postinfection [dpi]) time point postinfection and at a late (4 dpi) time point postinfection. The early inhibition of HLA class II expression and antigen presentation was not dependent on active virus replication, since UV-inactivated virus induced downregulation of HLA-DR and inhibition of T-cell proliferation at 1 dpi. In contrast, the late effect required virus replication and was dependent on the expression of the HCMV unique short (US) genes US1 to -9 or US11 in 77% of the samples. HCMV-treated macrophages were completely devoid of T-cell stimulation capacity at 1 and 4 dpi. However, while downregulation of HLA class II expression was rather mild, a 66 to 90% reduction in proliferative T-cell response was observed. This discrepancy was due to undefined soluble factors produced in HCMV-infected cell cultures, which did not include interleukin-10 and transforming growth factor β1. These results suggest that HCMV reduces expression of HLA class II molecules on HCMV-infected macrophages and inhibits T-cell proliferation by different distinct pathways.Keywords
This publication has 55 references indexed in Scilit:
- Surface Expression of HLA-E, an Inhibitor of Natural Killer Cells, Enhanced by Human Cytomegalovirus gpUL40Science, 2000
- The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cellsNature, 1997
- Regulation of transcription of MHC class II genesCurrent Opinion in Immunology, 1997
- Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene productNature, 1996
- Human Cytomegalovirus Inhibits Peptide Translocation into the Endoplasmic Reticulum for MHC Class I AssemblyJournal of General Virology, 1996
- The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the CytosolCell, 1996
- Cytomegalovirus Infection Is Associated With Absence Of Alveolar Epithelial Cell HLA Class II Antigen ExpressionThe Journal of Infectious Diseases, 1995
- Cytotoxic T Cells Specific for Cytomegalovirus: A Potential Therapy for Immunocompromised PatientsClinical Infectious Diseases, 1991
- INABILITY OF CYTOMEGALOVIRUS INFECTION OF CULTURED ENDOTHELIAL CELLS TO INDUCE HLA CLASS II ANTIGEN EXPRESSIONTransplantation, 1990
- IgG Antibodies to Cytomegalovirus in a Normal Urban Swedish PopulationScandinavian Journal of Infectious Diseases, 1984